Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

despite lung disease being one of the UK’s greatest healthcare challenges. “The N-Tidal Diagnose device represents the first ...

Plasma-based molecular residual disease analysis shows the potential to predict disease recurrence in lung cancer patients by 4.7 months.

Exophiala, a genus of saprotrophic black fungi commonly found in the environment, is typically associated with cutaneous infections in immunocompromised hosts and rarely manifests as pneumonia. Here, ...

A new study finds that KL-6 and hSP-D levels can help predict progression of interstitial lung disease in patients with ...

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

Lung disease test done by AI to be rolled out in GP surgeries - ‘Game-changing’ AI-driven lung test set for GP surgery ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...